Page last updated: 2024-11-02

pargyline and Dyskinesia, Drug-Induced

pargyline has been researched along with Dyskinesia, Drug-Induced in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research Excerpts

ExcerptRelevanceReference
"0 mg/kg) attenuated, in a dose-response fashion, the induction of stereotyped behavior and hyperactivity by pargyline (0."1.26Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. ( Freemark, M; Gillin, JC; Moja, EA; Stoff, DM; Wyatt, RJ, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freemark, M1
Stoff, DM1
Moja, EA1
Gillin, JC1
Wyatt, RJ1

Other Studies

1 other study available for pargyline and Dyskinesia, Drug-Induced

ArticleYear
Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats.
    Biological psychiatry, 1978, Volume: 13, Issue:4

    Topics: Animals; Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce

1978